The second in our neuropsychology series!

According to the Surgeon General’s Report on Alcohol, Drugs, and Health, substance misuse is estimated to cost society $442 billion each year in health care costs, lost productivity, and criminal justice expenses. In this webinar, we will review substance misuse in the United States and discuss differences between substance use and substance use disorders. We will highlight the impact of COVID-19 on the recovery community and several important consequences. The webinar will review of the neurobiology of addiction and what is understood at a mechanistic level with regard to the development of addiction. Finally, we will discuss assessment and treatment approaches to help providers more accurately understand and treat individuals who are experiencing addiction. This webinar will discuss the scientific underpinnings of addiction as well as provide practical information for everyday practice.

Learning Objectives:
By the end of this session, participants will be able to:

Discuss the prevalence and impact of addiction in the United States, addressing the impact of COVID-19.
Describe the neurobiology of addiction and appreciate the complex interplay of genetics and environment.
Address assessment and key treatment approaches when working with individuals with addiction and substance use disorders.

Qualification Level Required: A

Instructional Level: Introductory

Target Audience: Psychologists, neuropsychologists, mental health counselors, parents, teachers, addiction specialists

Melissa E. Milanak PhD

Clinical Assessment Advisor at PAR, Inc. mmilanak@parinc.com

Appearances